News Author: HT Staff Publish date: January 27, 2014
Credit: Chad McNeeley
A music therapy intervention can help adolescents and young adults (AYAs) cope with cancer and its treatment, according to re...
News Author: HT Staff Publish date: January 27, 2014
Credit: Steven Harbour
The phase 3 RESONATE study has been stopped early due to positive results in patients receiving ibrutinib.
In this trial,...
News Author: HT Staff Publish date: January 25, 2014
Scientists have found evidence to suggest that a genetic alteration in osteoblasts can induce acute myeloid leukemia (AML).
And this provides a pot...
News Author: HT Staff Publish date: January 24, 2014
Credit: CDC
A new study suggests that “practice makes perfect” when it comes to caring for patients with severe sepsis.
Researchers found that p...
News Author: HT Staff Publish date: January 24, 2014
Researchers may have discovered why African Americans on dialysis sometimes require higher doses of erythropoietin-stimulating agents (ESAs) than dial...
News Author: HT Staff Publish date: January 23, 2014
Louis Heiser & Robert Ackland
Bioengineers say they’ve found a way to accurately predict blood vessel growth, and this finding has implications...
News Author: HT Staff Publish date: January 23, 2014
Credit: Esther Dyson
New research suggests that drugs are often rejected by the US Food and Drug Administration (FDA), not because they are unsafe ...
News Author: HT Staff Publish date: January 23, 2014
The PI3K delta inhibitor idelalisib could turn chronic lymphocytic leukemia (CLL) into a highly treatable disease, according to the lead investigator ...
News Author: HT Staff Publish date: January 22, 2014
Credit: FDA
A new study suggests the US Food and Drug Administration (FDA) does not hold drug trials to the same set of standards.
The research ...
News Author: HT Staff Publish date: January 22, 2014
Credit: Linda Bartlett
The Japanese Ministry of Health, Labour and Welfare has approved brentuximab vedotin (Adcetris) for the treatment of patient...
News Author: HT Staff Publish date: January 22, 2014
The US Food and Drug Administration (FDA) has acknowledged the current shortage of intravenous (IV) solutions, particularly 0.9% sodium chloride injec...
News Author: HT Staff Publish date: January 21, 2014
Credit: CDC
A new report suggests that many health plans in the insurance exchanges mandated by the Affordable Care Act (ACA) will impose high out-...
News Author: HT Staff Publish date: January 20, 2014
Cytotoxic T lymphocytes (CTLs) targeting Epstein-Barr virus (EBV) proteins appear to be a promising treatment option for patients with aggressive lymp...
News Author: HT Staff Publish date: January 19, 2014
Ariad Pharmaceuticals, Inc., has begun shipping the drug to Biologics, Inc., its exclusive specialty pharmacy.
News Author: HT Staff Publish date: January 18, 2014
Credit: Mass.
